FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Douglas Weaver

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Sean van Diepen; Arnoud W J van't Hof; W Douglas Weaver; Kyle R White; Petr Widimsky; Diego Ardissino; Paul W Armstrong; Renato D Lopes; Frans Van de Werf; Christopher B Granger
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.
Quinn R Pack; W Douglas Weaver; Steven J Keteyian; Patrick E McBride; Henry E Kim
Current status of preventive cardiology training among United States cardiology fellowships and comparison to training guidelines.
Michael P Hudson; Paul W Armstrong; William W O'Neil; Amanda L Stebbins; W Douglas Weaver; Petr Widimsky; Philip E Aylward; Witold Ruzyllo; David Holmes; Kenneth W Mahaffey; Christopher B Granger
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Douglas Weaver (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sean van Diepen; Arnoud W J van't Hof; W Douglas Weaver; Kyle R White; Petr Widimsky; Diego Ardissino; Paul W Armstrong; Renato D Lopes; Frans Van de Werf; Christopher B Granger
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.
Circulation. Cardiovascular quality and outcomes 2012;5(4):437-44.
2012: Quinn R Pack; W Douglas Weaver; Steven J Keteyian; Patrick E McBride; Henry E Kim
Current status of preventive cardiology training among United States cardiology fellowships and comparison to training guidelines.
The American journal of cardiology 2012;110(1):124-8.
2011: Michael P Hudson; Paul W Armstrong; William W O'Neil; Amanda L Stebbins; W Douglas Weaver; Petr Widimsky; Philip E Aylward; Witold Ruzyllo; David Holmes; Kenneth W Mahaffey; Christopher B Granger
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
Circulation. Cardiovascular quality and outcomes 2011;4(2):183-92.
2010: Michael Hudson; Adam Greenbaum; Laura Brenton; C Michael Gibson; Robert Siegel; Lisa R Reeves; Miguel Fiol Sala; George McKendall; Jorge Bluguermann; Debra Echt; Erik Ohman; W Douglas Weaver
Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial.
JACC. Cardiovascular interventions 2010;3(3):352-9.
2009: Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
European heart journal 2009;30(16):2019-28.
2007: Adam B Greenbaum; Erik Ohman; C Michael Gibson; Steven Borzak; Amanda L Stebbins; Mei Lu; Michel R Le May; Jill E Stankowski; Hakan Emanuelsson; W Douglas Weaver
Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.
American heart journal 2007;154(4):702-9.
2007: Sanjaya Khanal; Omar Obeidat; Michael P Hudson; Mouaz Al-Mallah; Mary Bloome; Mei Lu; Adam B Greenbaum; Aaron D Kugelmass; W Douglas Weaver
Active Lipid Management In Coronary Artery Disease (ALMICAD) study.
The American journal of medicine 2007;120(8):734.e11-7.
2007: Karen P Alexander; L Kristin Newby; Paul W Armstrong; Christopher P Cannon; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan Krumholz; Erik Ohman
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2570-89.
2007: Karen P Alexander; L Kristin Newby; Christopher P Cannon; Paul W Armstrong; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan Krumholz; Erik Ohman
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2549-69.
2007: Mohamad C N Sinno; Sanjaya Khanal; Mouaz Al-Mallah; Muhammad Arida; W Douglas Weaver
The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
American heart journal 2007;153(4):579-86.
2007: Zehra Jaffery; Marcin Kowalski; W Douglas Weaver; Sanjaya Khanal
A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2007;31(4):691-7.
2006: Michael P Hudson; Paul W Armstrong; Witold Ruzyllo; Jose Brum; Lisa Cusmano; Piotr Krzeski; Robert Lyon; Miguel Quinones; Pierre Theroux; Diana Sydlowski; Henry E Kim; Mario J. Garcia; Wael A Jaber; W Douglas Weaver
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
Journal of the American College of Cardiology 2006;48(1):15-20.
2006: Abhinav Goyal; Kenneth W Mahaffey; Jyotsna Garg; Jose C Nicolau; Judith S Hochman; W Douglas Weaver; Pierre Theroux; Gustavo B F Oliveira; Thomas G Todaro; Christopher F Mojcik; Paul W Armstrong; Christopher B Granger
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.
European heart journal 2006;27(11):1289-97.
2006: Mouaz Al-Mallah; Imad M Tleyjeh; Ahmed A Abdel-Latif; W Douglas Weaver
Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials.
Journal of the American College of Cardiology 2006;47(8):1576-83.
2006: Justin A Ezekowitz; Pierre Théroux; Weiching Chang; Kenneth W Mahaffey; Christopher B Granger; W Douglas Weaver; Judith S Hochman; Paul W Armstrong
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction.
The Canadian journal of cardiology 2006;22(5):393-7.
2006: Paul W Armstrong; Kenneth W Mahaffey; Wei-Ching Chang; W Douglas Weaver; Judith S Hochman; Pierre Theroux; Scott A Rollins; Thomas G Todaro; Christopher B Granger
Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction.
American heart journal 2006;151(4):787-90.
2006: Adam B Greenbaum; Cindy L Grines; John A Bittl; Richard C Becker; Dean J Kereiakes; Ian C Gilchrist; Jane Clegg; Jill E Stankowski; Donna R Grogan; Robert A Harrington; Hakan Emanuelsson; W Douglas Weaver
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
American heart journal 2006;151(3):689.e1-689.e10.
2006: Teresa L Kauf; Eric J Velazquez; David R Crosslin; W Douglas Weaver; Rafael Diaz; Christopher B Granger; john mcmurray; Jean-Lucien Rouleau; Philip E Aylward; Harvey D White; Robert M Califf; Kevin Schulman
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
American heart journal 2006;151(1):206-12.
2005: Camille G Frazier; Svati H Shah; Paul W Armstrong; Manjushri Bhapkar; Darren K McGuire; Zygmunt Sadowski; Arni Kristinsson; Philip E Aylward; Werner W Klein; W Douglas Weaver; L Kristin Newby
Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials.
American heart journal 2005;150(6):1260-7.
2005: Aslan T Turer; Kenneth W Mahaffey; Dianne Gallup; W Douglas Weaver; Robert H Christenson; Nathan R Every; Erik Ohman
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction.
Current controlled trials in cardiovascular medicine 2005;6():12.
2005: Kenneth W Mahaffey; Matthew T Roe; Rakhi Kilaru; John K French; John H Alexander; Lisa G Berdan; Frans Van de Werf; Maarten L Simoons; W Douglas Weaver; Harvey D White; A Michael Lincoff; Neal S Kleiman; Eric J Topol; Robert A Harrington
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
The American journal of cardiology 2005;95(12):1404-8.
2005: Mouaz Al-Mallah; Khaled Dajani; Michael Hudson; Hrishikesh Iyengar; Noel Gutierrez; W Douglas Weaver; Sanjaya Khanal
Long-term outcomes based on time-to-angioplasty in patients admitted with non-ST-segment elevation acute coronary syndromes.
The Journal of invasive cardiology 2005;17(5):251-5.
2005: Manesh R Patel; Kenneth W Mahaffey; Paul W Armstrong; W Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott A Rollins; Pierre Theroux; Witold Ruzyllo; Jose C Nicolau; Christopher B Granger
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).
The American journal of cardiology 2005;95(5):614-8.
2004: Eric J Velazquez; Gary S Francis; Paul W Armstrong; Philip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek H van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; john mcmurray; Marc A Pfeffer; Robert M Califf
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Frank Bogun; Daejoon Anh; Gautham Kalahasty; Erik Wissner; Chadi Bou Serhal; Rabih Bazzi; W Douglas Weaver; CD Schuger
Misdiagnosis of atrial fibrillation and its clinical consequences.
The American journal of medicine 2004;117(9):636-42.
2004: Sanjaya Khanal; Omar Obeidat; Mei Lu; Lori Douthat; Michael P Hudson; Adam B Greenbaum; Aaron D Kugelmass; W Douglas Weaver
Dyslipidemia in patients with angiographically confirmed coronary artery disease--an opportunity for improvement.
Clinical cardiology 2004;27(10):577-80.
2004: Ajay Manhapra; John G Canto; Viola Vaccarino; Lori Parsons; Catarina I Kiefe; Hal V Barron; William J Rogers; W Douglas Weaver; Steven Borzak
Relation of age and race with hospital death after acute myocardial infarction.
American heart journal 2004;148(1):92-8.
2004: David E Kandzari; Christopher B Granger; Maarten L Simoons; Harvey D White; R John Simes; Kenneth W Mahaffey; Joel Gore; W Douglas Weaver; William T Longstreth; Amanda L Stebbins; Kerry L Lee; Robert M Califf; Eric J Topol
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
The American journal of cardiology 2004;93(4):458-61.
2004: Mushabbar A Syed; Steven Borzak; Abed Asfour; Madhavi Gunda; Omar Obeidat; Sabina A Murphy; Raymond J Gibbons; Steven G Gourlay; Hal V Barron; W Douglas Weaver; Michael Hudson
Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction.
American heart journal 2004;147(2):275-80.
2004: Darren K McGuire; L Kristin Newby; Manjushri Bhapkar; David J Moliterno; Judith S Hochman; Werner W Klein; W Douglas Weaver; Matthias Pfisterer; Ramón Corbalán; Mikael Dellborg; Christopher B Granger; Frans Van de Werf; Eric J Topol; Robert M Califf
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
American heart journal 2004;147(2):246-52.
2004: Christopher B Granger; W Douglas Weaver
Reducing cardiac events after acute coronary syndromes.
Reviews in cardiovascular medicine 2004;5 Suppl 5():S39-46.
2003: Kenneth W Mahaffey; Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; W Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
Circulation 2003;108(10):1176-83.
2003: Christopher B Granger; Kenneth W Mahaffey; W Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Scott A Rollins; Thomas G Todaro; Jose C Nicolau; Witold Ruzyllo; Paul W Armstrong
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
Circulation 2003;108(10):1184-90.
2003: James McCord; Richard M Nowak; Michael P Hudson; Peter A McCullough; Michael C Tomlanovich; Gordon Jacobsen; Glenn Tokarski; Nabil Khoury; W Douglas Weaver
The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome.
Annals of emergency medicine 2003;42(3):343-50.
2003: Mauricio G. Cohen; Enrique Tuero; Jorge Bluguermann; Rubén Kevorkian; Daniel H Berrocal; Oscar Carlevaro; Eduardo Picabea; Michael P Hudson; Robert J Siegel; Lori Douthat; Adam B Greenbaum; Debra Echt; W Douglas Weaver; Liliana Grinfeld
Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction.
The American journal of cardiology 2003;92(4):454-7.
2002: Peter A McCullough; Richard M Nowak; Craig Foreback; Glenn Tokarski; Michael C Tomlanovich; Nabil Khoury; W Douglas Weaver; Keisha R Sandberg; James McCord
Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2002;9(12):1389-96.
2002: Peter A McCullough; Richard M Nowak; Craig Foreback; Glenn Tokarski; Michael C Tomlanovich; Nabil Khoury; W Douglas Weaver; Keisha R Sandberg; James McCord
Emergency evaluation of chest pain in patients with advanced kidney disease.
Archives of internal medicine 2002;162(21):2464-8.
2002: W Douglas Weaver; Mary Ann Peberdy
Defibrillators in public places--one step closer to home.
The New England journal of medicine 2002;347(16):1223-4.
2002: R David Anderson; Harvey D White; Erik Ohman; Galen S Wagner; Mitchell W Krucoff; Paul W Armstrong; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; Robert M Califf; Eric J Topol
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.
American heart journal 2002;144(1):81-8.
2002: L Kristin Newby; Arni Kristinsson; Manjushri Bhapkar; Philip E Aylward; Alexios P Dimas; Werner W Klein; Darren K McGuire; David J Moliterno; Freek W A Verheugt; W Douglas Weaver; Robert M Califf
Early statin initiation and outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2002;287(23):3087-95.
2002: Felix Zijlstra; A Patel; M Jones; C L Grines; S Ellis; E Garcia; Liliana Grinfeld; R J Gibbons; E E Ribeiro; F Ribichini; C Granger; F Akhras; W Douglas Weaver; R J Simes
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction.
European heart journal 2002;23(7):550-7.
2002: Peter A McCullough; Edward F Philbin; John A Spertus; Scott S Kaatz; Keisha R Sandberg; W Douglas Weaver
Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.
Journal of the American College of Cardiology 2002;39(1):60-9.
2001: Sanjaya Khanal; W Douglas Weaver
Provisional versus routine coronary stenting. A review.
Minerva cardioangiologica 2001;49(6):395-401.
2001: Ajay Manhapra; John G Canto; Hal V Barron; Judith A Malmgren; H Taylor; William J Rogers; W Douglas Weaver; Nathan R Every; Steven Borzak
Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics.
American heart journal 2001;142(4):604-10.
2001: James McCord; Richard M Nowak; Peter A McCullough; Craig Foreback; Steven Borzak; Glenn Tokarski; Michael C Tomlanovich; Gordon Jacobsen; W Douglas Weaver
Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I.
Circulation 2001;104(13):1483-8.
1999: Erik Ohman; Paul W Armstrong; Harvey D White; Christopher B Granger; Robert G Wilcox; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; C Cianciolo; Robert M Califf; Eric J Topol
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.
The American journal of cardiology 1999;84(11):1281-6.
1999: Kenneth W Mahaffey; Christopher B Granger; Michael A Sloan; Cynthia L Green; Joel M Gore; W Douglas Weaver; Harvey D White; Maarten L Simoons; Gabriel I Barbash; Eric J Topol; Robert M Califf
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
American heart journal 1999;138(3 Pt 1):493-9.
1999: Judith S Hochman; Jacqueline E Tamis; T D Thompson; W Douglas Weaver; Harvey D White; Frans Van de Werf; Philip E Aylward; Eric J Topol; Robert M Califf
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators.
The New England journal of medicine 1999;341(4):226-32.
1999: K E Corey; Charles Maynard; Olle Pahlm; M L Wilkins; ST Anderson; M D Cerqueira; Aurora D Pryor; Merritt H Raitt; R H Startt Selvester; J Turner; W Douglas Weaver; Galen S Wagner
Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation.
The American journal of cardiology 1999;83(6):826-31.
1999: C Y Tung; Christopher B Granger; Michael A Sloan; Eric J Topol; J D Knight; W Douglas Weaver; Kenneth W Mahaffey; H White; Nancy E Clapp-Channing; Maarten L Simoons; J M Gore; Robert M Califf; Daniel B Mark
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
Circulation 1999;99(3):370-6.
1998: Michael A Sloan; Cathy A Sila; Kenneth W Mahaffey; Christopher B Granger; W T Longstreth; Peter J Koudstaal; Harvey D White; Joel M Gore; Maarten L Simoons; W Douglas Weaver; Cynthia L Green; Eric J Topol; Robert M Califf
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Circulation 1998;98(14):1376-82.
1998: J Hochrein; F Sun; Karen S Pieper; Kerry L Lee; K B Gates; Paul W Armstrong; W Douglas Weaver; Shaun G Goodman; Eric J Topol; Robert M Califf; Christopher B Granger; Galen S Wagner
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries.
The American journal of cardiology 1998;81(9):1078-84.
1998: Kenneth W Mahaffey; Christopher B Granger; Michael A Sloan; TD Thompson; Joel M Gore; W Douglas Weaver; Harvey D White; Maarten L Simoons; Gabriel I Barbash; Eric J Topol; Robert M Califf
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.
Circulation 1998;97(8):757-64.
1998: James Gebel; Cathy A Sila; Michael A Sloan; Christopher B Granger; Kenneth W Mahaffey; J Weisenberger; Cynthia L Green; Harvey D White; Joel M Gore; W Douglas Weaver; Robert M Califf; Eric J Topol
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Stroke; a journal of cerebral circulation 1998;29(3):563-9.
1997: W Douglas Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; Liliana Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.
JAMA : the journal of the American Medical Association 1997;278(23):2093-8.
1997: M L Wilkins; Charles Maynard; B H Annex; Peter Clemmensen; W J Elias; R S Gibson; K L Lee; Aurora D Pryor; Harry P Selker; J Turner; W Douglas Weaver; ST Anderson; Galen S Wagner
Admission prediction of expected final myocardial infarct size using weighted ST-segment, Q wave, and T wave measurements.
Journal of electrocardiology 1997;30(1):1-7.